Premium
The Fate of G3pT1 Bladder Cancer
Author(s) -
JENKINS B. J.,
NAUTHMISIR R. R.,
MARTIN J. E.,
FOWLER C. G.,
HOPESTONE H. F.,
BLANDY J. P.
Publication year - 1989
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1989.tb05319.x
Subject(s) - medicine , radiation therapy , carcinoma in situ , carcinoma , bladder cancer , resection , urology , cancer , oncology , surgery
Summary— Poorly differentiated (G3) cancers are known to have a worse prognosis than other superficial bladder tumours. In the period 1976 to 1987, 53 patients with G3pT1 disease were treated by radical radiotherapy with a 5‐year survival rate of 64%. Thirteen patients (25%) developed an invasive tumour during the follow‐up period. The presence of secondary carcinoma in situ was associated with a poor prognosis. These results are better than those reported for transurethral resection alone and suggest that radiotherapy is the treatment of choice in G3 superficial tumours.